Apatinib for the treatment of pulmonary epithelioid hemangioendothelioma: A case report and literature review

RATIONALE: Pulmonary epithelioid hemangioendothelioma (P-EHE) is a rare tumor, with no established standard treatment. Overexpression of vascular endothelial growth factor receptor 2 (VEGFR-2) has been reported in some P-EHE patients. Apatinib, a new small molecule tyrosine kinase inhibitor that spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zhipeng, Wang, Hanying, Jiang, Hanliang, Chen, Enguo, Zhang, Jun, Xie, Xinyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690741/
https://www.ncbi.nlm.nih.gov/pubmed/29137048
http://dx.doi.org/10.1097/MD.0000000000008507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690741/
https://www.ncbi.nlm.nih.gov/pubmed/29137048
http://dx.doi.org/10.1097/MD.0000000000008507

Ejemplares similares